Bayer Intellectual Property GMBH v. Breckenridge Pharmaceutical Inc.

Application Number	Patent Number	External Links
-	US7157456	Espacenet Google Patents
-	US7592339	Espacenet Google Patents

COMPLAINT filed against Breckenridge Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1969196.) - filed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals Inc., Bayer Pharma AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(aah) (Entered: 07/26/2016)

2016-07-25

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 07/26/2016)

2016-07-25

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/28/2016. Date of Expiration of Patent: See attached form.Thirty Month Stay Deadline: 1/1/2019. (aah) (Entered: 07/26/2016)

2016-07-25

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,157,456 B2; 7,592,339 B2; (aah) (Entered: 07/26/2016)

2016-07-25

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH, Bayer Pharma AG filed by Bayer Intellectual Property GMBH, Bayer Pharma AG.(aah) (Entered: 07/26/2016)

2016-07-25

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals Inc. filed by Janssen Pharmaceuticals Inc.(aah) (Entered: 07/26/2016)

2016-07-25

1

View

Summons Issued with Magistrate Consent Notice attached as to Breckenridge Pharmaceutical Inc. on 7/26/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (aah)

2016-07-26

1

No Actions

Summons Issued

2016-07-26

1

No Actions

Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb)

2016-07-27

1

No Actions

Case Assigned/Reassigned

2016-07-27

1

No Actions

REQUEST FOR WAIVER of Service sent to Breckenridge Pharmaceutical, Inc., c/o John C. Phillips, Jr, Esquire on July 26, 2016 by Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. Waiver of Service due by 9/26/2016. (Fahnestock, Derek) (Entered: 08/01/2016)

2016-08-01

1

View

WAIVER OF SERVICE returned executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals Inc., Bayer Pharma AG: For Breckenridge Pharmaceutical Inc. waiver sent on 7/26/2016, answer due 9/26/2016. (Fahnestock, Derek) (Entered: 08/01/2016)

2016-08-01

1

View

STIPULATION and [Proposed] Order of Consolidation by Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 08/23/2016)

2016-08-23

1

View

SO ORDERED

2016-08-24

1

No Actions

Create Case Association - dkt in member case for Consol or MDL

2016-08-24

1

No Actions

SO ORDERED, re (118 in 1:15-cv-00902-SLR, 9 in 1:16-cv-00628-SLR) STIPULATION AND ORDER OF CONSOLIDATION. Signed by Judge Sue L. Robinson on 8/24/2016. ALL FUTURE FILINGS SHALL BE MADE IN CIVIL NO. 15-902-SLR ONLY. Associated Cases: 1:15-cv-00902-SLR, 1:16-cv-00628-SLR(nmfn)

2016-08-24

1

No Actions

Case associated with lead case: Create association to 1:15-cv-00902-SLR. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 15-902-SLR. (nmfn)

2016-08-24

1

No Actions

Case Assigned/Reassigned

2017-01-04

1

No Actions

Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:16-cv-00064-RGA, 1:16-cv-00242-RGA, 1:16-cv-00628-RGA (rjb)

2017-01-04

1

No Actions

ORDER - DESIGNATION OF DISTRICT JUDGE FOR SERVICE IN ANOTHER DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Lawrence F. Stengel of the United States District Court for the Eastern District of Pennsylvania. Signed by Chief Judge D. Brooks Smith of the United States Court of Appeals for the Third Circuit on 11/29/2017. (rjb) (Entered: 11/29/2017)

2017-11-29

1

View

Case Assigned (in lieu of Vacant Judgeship)

2017-11-29

1

No Actions

Case Reassigned to Judge Lawrence F. Stengel of the Eastern District of Pennsylvania (in lieu of Vacant Judgeship). Please include the initials of the Judge (LS) after the case number on all documents filed. Associated Cases: 1:15-cv-00902-LS, 1:16-cv-00064-LS, 1:16-cv-00242-LS, 1:16-cv-00628-LS (rjb)

2017-11-29

1

No Actions

Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:15-cv-00902-RGA, 1:16-cv-00064-RGA, 1:16-cv-00242-RGA, 1:16-cv-00628-RGA (rjb)

2018-09-07

1

No Actions

CASE CLOSED per entry of D.I. 327 in Lead Civil Action 15-902-RGA. (nms)

2018-09-10

1

No Actions

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,157,456 B2; 7,592,339 B2. (Attachments: # 1 Order)(nms) (Entered: 09/11/2018)

2018-09-11

1

View

Overview

Parties

Plaintiff

Breckenridge Pharmaceutical Inc.

Represented By

Counter Defendant

Bayer Intellectual Property GMBH

Represented By

Defendant

Janssen Pharmaceuticals Inc.

Represented By

Bayer Pharma AG

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 07/26/2016)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/28/2016. Date of Expiration of Patent: See attached form.Thirty Month Stay Deadline: 1/1/2019. (aah) (Entered: 07/26/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,157,456 B2; 7,592,339 B2; (aah) (Entered: 07/26/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH, Bayer Pharma AG filed by Bayer Intellectual Property GMBH, Bayer Pharma AG.(aah) (Entered: 07/26/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals Inc. filed by Janssen Pharmaceuticals Inc.(aah) (Entered: 07/26/2016)

Summons Issued with Magistrate Consent Notice attached as to Breckenridge Pharmaceutical Inc. on 7/26/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (aah)

Summons Issued

Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb)

Case Assigned/Reassigned

REQUEST FOR WAIVER of Service sent to Breckenridge Pharmaceutical, Inc., c/o John C. Phillips, Jr, Esquire on July 26, 2016 by Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. Waiver of Service due by 9/26/2016. (Fahnestock, Derek) (Entered: 08/01/2016)

WAIVER OF SERVICE returned executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals Inc., Bayer Pharma AG: For Breckenridge Pharmaceutical Inc. waiver sent on 7/26/2016, answer due 9/26/2016. (Fahnestock, Derek) (Entered: 08/01/2016)

STIPULATION and [Proposed] Order of Consolidation by Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 08/23/2016)

SO ORDERED

Create Case Association - dkt in member case for Consol or MDL

SO ORDERED, re (118 in 1:15-cv-00902-SLR, 9 in 1:16-cv-00628-SLR) STIPULATION AND ORDER OF CONSOLIDATION. Signed by Judge Sue L. Robinson on 8/24/2016. ALL FUTURE FILINGS SHALL BE MADE IN CIVIL NO. 15-902-SLR ONLY. Associated Cases: 1:15-cv-00902-SLR, 1:16-cv-00628-SLR(nmfn)

Case associated with lead case: Create association to 1:15-cv-00902-SLR. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 15-902-SLR. (nmfn)

Case Assigned/Reassigned

Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:16-cv-00064-RGA, 1:16-cv-00242-RGA, 1:16-cv-00628-RGA (rjb)

Case Assigned (in lieu of Vacant Judgeship)

Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:15-cv-00902-RGA, 1:16-cv-00064-RGA, 1:16-cv-00242-RGA, 1:16-cv-00628-RGA (rjb)

CASE CLOSED per entry of D.I. 327 in Lead Civil Action 15-902-RGA. (nms)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,157,456 B2; 7,592,339 B2. (Attachments: # 1 Order)(nms) (Entered: 09/11/2018)

Bayer Intellectual Property GMBH v. Breckenridge Pharmaceutical Inc.

Overview

Parties

Plaintiff

Breckenridge Pharmaceutical Inc. Follow

Represented By

Counter Defendant

Bayer Intellectual Property GMBH Follow

Represented By

Defendant

Janssen Pharmaceuticals Inc. Follow

Represented By

Bayer Pharma AG Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 07/26/2016)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/28/2016. Date of Expiration of Patent: See attached form.Thirty Month Stay Deadline: 1/1/2019. (aah) (Entered: 07/26/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,157,456 B2; 7,592,339 B2; (aah) (Entered: 07/26/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH, Bayer Pharma AG filed by Bayer Intellectual Property GMBH, Bayer Pharma AG.(aah) (Entered: 07/26/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals Inc. filed by Janssen Pharmaceuticals Inc.(aah) (Entered: 07/26/2016)

Summons Issued with Magistrate Consent Notice attached as to Breckenridge Pharmaceutical Inc. on 7/26/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (aah)

Summons Issued

Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb)

Case Assigned/Reassigned

REQUEST FOR WAIVER of Service sent to Breckenridge Pharmaceutical, Inc., c/o John C. Phillips, Jr, Esquire on July 26, 2016 by Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. Waiver of Service due by 9/26/2016. (Fahnestock, Derek) (Entered: 08/01/2016)

WAIVER OF SERVICE returned executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals Inc., Bayer Pharma AG: For Breckenridge Pharmaceutical Inc. waiver sent on 7/26/2016, answer due 9/26/2016. (Fahnestock, Derek) (Entered: 08/01/2016)

STIPULATION and [Proposed] Order of Consolidation by Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 08/23/2016)

SO ORDERED

Create Case Association - dkt in member case for Consol or MDL

SO ORDERED, re (118 in 1:15-cv-00902-SLR, 9 in 1:16-cv-00628-SLR) STIPULATION AND ORDER OF CONSOLIDATION. Signed by Judge Sue L. Robinson on 8/24/2016. ALL FUTURE FILINGS SHALL BE MADE IN CIVIL NO. 15-902-SLR ONLY. Associated Cases: 1:15-cv-00902-SLR, 1:16-cv-00628-SLR(nmfn)

Case associated with lead case: Create association to 1:15-cv-00902-SLR. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 15-902-SLR. (nmfn)

Case Assigned/Reassigned

Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:16-cv-00064-RGA, 1:16-cv-00242-RGA, 1:16-cv-00628-RGA (rjb)

Case Assigned (in lieu of Vacant Judgeship)

Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:15-cv-00902-RGA, 1:16-cv-00064-RGA, 1:16-cv-00242-RGA, 1:16-cv-00628-RGA (rjb)

CASE CLOSED per entry of D.I. 327 in Lead Civil Action 15-902-RGA. (nms)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,157,456 B2; 7,592,339 B2. (Attachments: # 1 Order)(nms) (Entered: 09/11/2018)

Track Case Updates

Breckenridge Pharmaceutical Inc.

Bayer Intellectual Property GMBH

Janssen Pharmaceuticals Inc.

Bayer Pharma AG